Here, we report that the pharmacologic inhibition of c-Abl prevents hAha1 interaction with hHsp90α and hypersensitizes renal cell carcinoma (RCC) to Hsp90 inhibitors in vitro and ex vivo. The gene discussed is ABL1; the disease is renal cell carcinoma.